There were no significant differences in the relative count of CD4+ T lymphocytes between patients with moderate (43.60% (34.37; 50.37) and severe 39.50% (31.73; 43.71)) COVID-19 patients and healthy donor’s group (45.47% (40.65; 48.62)) (Figure 1C). Here, CD4 is linked to COVID-19.